Royalty Pharmaìs Acquisition of Royalty Interest from GSK

Martina Bellini North America, North America Legal Chronicle
Tagged:

Dechert advised Royalty Pharma on the deal.Royalty Pharma plc executed its acquisition of a royalty interest in the cabozantinib products Cabometyx and Cometriq from GlaxoSmithKline (GSK)…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here